CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 39 filers reported holding CUE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,605,849 | -32.4% | 698,195 | +7.2% | 0.00% | – |
| Q2 2023 | $2,377,227 | +371.8% | 651,295 | +361.4% | 0.00% | – |
| Q1 2023 | $503,916 | -37.4% | 141,153 | -50.0% | 0.00% | – |
| Q4 2022 | $804,572 | +155.4% | 282,306 | +100.0% | 0.00% | – |
| Q3 2022 | $315,000 | -20.3% | 141,153 | -11.0% | 0.00% | – |
| Q2 2022 | $395,000 | -88.9% | 158,604 | -78.2% | 0.00% | – |
| Q1 2022 | $3,548,000 | -81.1% | 727,023 | -56.3% | 0.00% | -100.0% |
| Q4 2021 | $18,800,000 | -1.2% | 1,662,252 | +27.2% | 0.00% | 0.0% |
| Q3 2021 | $19,035,000 | +11.1% | 1,306,446 | -11.1% | 0.00% | 0.0% |
| Q2 2021 | $17,126,000 | +2.4% | 1,470,075 | +7.3% | 0.00% | 0.0% |
| Q1 2021 | $16,721,000 | -4.0% | 1,370,605 | -1.5% | 0.00% | 0.0% |
| Q4 2020 | $17,409,000 | -14.5% | 1,391,578 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $20,367,000 | -19.1% | 1,353,265 | +31.8% | 0.00% | -50.0% |
| Q2 2020 | $25,169,000 | +377.0% | 1,026,881 | +176.2% | 0.00% | – |
| Q1 2020 | $5,276,000 | -0.4% | 371,783 | +11.4% | 0.00% | – |
| Q4 2019 | $5,298,000 | +119.8% | 333,701 | +16.7% | 0.00% | – |
| Q3 2019 | $2,410,000 | -7.1% | 285,929 | -0.9% | 0.00% | – |
| Q2 2019 | $2,593,000 | +27.7% | 288,386 | +9.8% | 0.00% | – |
| Q1 2019 | $2,030,000 | +57.5% | 262,578 | -4.3% | 0.00% | – |
| Q4 2018 | $1,289,000 | -47.0% | 274,358 | +2.0% | 0.00% | – |
| Q3 2018 | $2,432,000 | -5.7% | 268,981 | +23.7% | 0.00% | – |
| Q2 2018 | $2,579,000 | +55.5% | 217,454 | +84.3% | 0.00% | – |
| Q1 2018 | $1,658,000 | – | 118,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |